LED Technologies, LLC announced today that the U.S. Food and Drug Administration (FDA) cleared their DPL™ Therapy System for the relaxation of muscles and relief of muscle spasms, temporary relief of minor muscle and joint aches, pains and stiffness; temporary relief of minor pain and stiffness associated with arthritis; and to temporarily increase local blood circulation. This clearance launches the way for the DPL™ Therapy System to bring temporary pain relief technology directly to the consumer without a prescription.
“This FDA clearance marks a considerable landmark for our company as we demonstrate our leadership in LED light-based science and develop innovative LED applications for the medical, professional and home use markets,” commented Brent Safer, Director of Operations and designer of the DPL™ Therapy System.
Minor pain is becoming all to common as our active and aging population become more prone to sports injuries, arthritis and the muscle and joint pain that accompanies the aging process. The American Pain Society estimates that 45% of the population seeks medical help for persistent pain sometimes in their lives. Medical economists estimate that pain costs the U.S. more than $100 billion every year, including over 500 million workdays lost and 40 million doctor visits.
The future of the DPL™ Therapy System is extremely bright as its applications expand beyond the minor pain relief field. Currently, LED Technologies, LLC is developing new DPL™ (Deep Penetrating Light) treatments for wrinkle reduction, TMJ, Fibromyalgia, Acne and a variety of other pain and wound healing applications.
“LED Technologies, LLC is committed to being the leader in LED light based therapy by bringing new and affordable medical applications to the consumer marketplace,” stated Ron Ferguson Director of Sales and Marketing for the company. “Our research shows great demand for effective and affordable medical applications that the individual can use in the privacy of their own homes.” The DPL™ Therapy System is a non-invasive, drug free therapy which can be utilized for a person’s individual needs.
LED Technologies, LLC was established in 2004 and has a Patent Pending on its proprietary design, consisting of two LED panels containing 154 880nm Infrared and 20 660nm Red LEDS. The DPL™ two panel system projects the largest surface area LED exposure in the home-based marketplace with a 9″X14″ (126 sq. inches) footprint. The system also includes a stand for use on the face and an easily adjustable strapping system which helps you place the panels almost anywhere on your body.
Technologies, LED. “FDA Clears The DPL (Deep Penetrating Light) Therapy System For Over-the-Counter – Home Use.” Medical News Today. MediLexicon, Intl., 18 Nov. 2008. Web.
16 Nov. 2013. <http://www.medicalnewstoday.com/releases/129684>
Technologies, L. (2008, November 18). “FDA Clears The DPL (Deep Penetrating Light) Therapy System For Over-the-Counter – Home Use.” Medical News Today. Retrieved from